Riskpilot← Back to searchSign inGet full accessCurInvest Aktiebolag
ABActiveOrg 5563836708Steglitsvägen 3General medical practice activities · NACE 8621Est. 19900 employees
Revenue 2025
SEK 0
EBITDA margin
—
+7% vs 2024
Equity ratio
99.7%
Financial strength
Net profit 2025
SEK 19K
-99% vs 2024
| Revenue | SEK 0 | — |
| EBITDA | SEK -8K | +7% |
| Net profit | SEK 19K | -99% |
| Total assets | SEK 3,3M | +1% |
| Equity | SEK 3,3M | +1% |
| Employees | 0 | — |
Legal name
CurInvest Aktiebolag
Org number
5563836708
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
21 februari 1990
Share capital
SEK 100 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget skall bedriva läkar- och tandläkarpraktik, utveckling, utprovning samt försäljning av medicinska och biologiska produkter, handel med värdepapper, äga och förvalta fastigheter samt idka därmed förenlig verksamhet.
Address
Steglitsvägen 3
Phone
+4631601000
Email
info@apss.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Staff expenses | — | — | — | — | — |
| EBITDA | −16 | 14 | −8 | −9 | −8 |
| Depreciation & amort. | −0 | — | — | — | — |
| EBIT | −16 | 14 | −8 | −9 | −8 |
| Net financials | 8 | 15 | 19 | 1 679 | 30 |
| Profit before tax | −8 | 29 | 11 | 1 670 | 22 |
| Tax | −0 | — | — | — | −2 |
| Net profit | −8 | 29 | 11 | 1 670 | 19 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 3 971 | 1 561 | 1 578 | 3 241 | 3 263 |
| Equity | 3 924 | 1 553 | 1 563 | 3 233 | 3 252 |
| Long-term debt | 0 | — | — | — | — |
| Short-term debt | 47 | 9 | 15 | 8 | 10 |
| Total debt | 47 | 9 | 15 | 8 | 10 |
EBITDA margin
-813800.0%
This company
15.8%
Market median
-5150733% vs market
20212025
Equity ratio
99.7%
This company
38.2%
Market median
+161% vs market
20212025
Return on equity
0.6%
This company
18.4%
Market median
-97% vs market
20212025
Net profit margin
1933500.0%
This company
8.1%
Market median
+23870270% vs market
20212025
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20212025
Debt / equity
0.00×
This company
0.62×
Market median
+100% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Former (2) | ||
JL Audit | Audit | 2020 – 2022 |
EE | Audit | 2022 – 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2020 | |
| Deputy Board Member | 2020 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of CurInvest Aktiebolag also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Jan Lennart Carlsson | Audit | 0 companies |
| Elin Eva Maria Nilsson | Audit | 0 companies |
| Nils Håkan Fredrik Gewalli | Board of Directors | 0 companies |
| Madeleine Linnéa Gewalli | Deputy Board Member | 0 companies |